<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-CEP-2869</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2869</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Оценка локального профиля цитокинов, экспрессируемых нативными клапанами сердца, полученными от пациентов с инфекционным эндокардитом</article-title><trans-title-group xml:lang="en"><trans-title>Cytokine expression profile of native heart valves obtained from patients with infective endocarditis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синицкая</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinitskaya</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Синицкая А.В. – к.б.н., научный сотрудник лаборатории геномной медицины отдела экспериментальной медицины </p><p>г. Кемерово</p></bio><bio xml:lang="en"><p>Sinitskaya A.V., PhD (Biology), Research Associate, Laboratory of Genomic Medicine, Department of Experimental Medicine </p><p>Kemerovo</p></bio><email xlink:type="simple">cepoav1991@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синицкий</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinitsky</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Синицкий М.Ю. – к.б.н., старший научный сотрудник лаборатории геномной медицины отдела экспериментальной медицины </p><p>г. Кемерово</p></bio><bio xml:lang="en"><p>Sinitsky M.Yu., PhD (Biology), Senior Research Associate, Laboratory of Genomic Medicine, Department of Experimental Medicine </p><p>Kemerovo</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Казачек</surname><given-names>Я. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kazachek</surname><given-names>Ya. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Казачек Я.В. – к.м.н., главный фармаколог</p><p>г. Кемерово</p></bio><bio xml:lang="en"><p>Kazachek Ya.V., PhD (Medicine), Chief Pharmacologist </p><p>Kemerovo</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Евтушенко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Evtushenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евтушенко А.В. – д.м.н., заведующий лабораторией пороков сердца </p><p>г. Кемерово</p></bio><bio xml:lang="en"><p>Evtushenko A.V., PhD, MD (Medicine), Head, Laboratory of Heart Diseases, Department of heart and vascular surgery </p><p>Kemerovo</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хуторная</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Khutornaya</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хуторная М.В. – младший научный сотрудник лаборатории геномной медицины отдела экспериментальной медицины </p><p>г. Кемерово</p></bio><bio xml:lang="en"><p>Khutornaya M.V., Junior Research Associate, Laboratory of Genomic Medicine, Department of Experimental Medicine </p><p>Kemerovo</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Асанов</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Asanov</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Асанов М.А. – младший научный сотрудник лаборатории геномной медицины отдела экспериментальной медицины </p><p>г. Кемерово</p></bio><bio xml:lang="en"><p>Asanov M.A., Junior Research Associate, Laboratory of Genomic Medicine, Department of Experimental Medicine </p><p>Kemerovo</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Поддубняк</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Poddubnyak</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Поддубняк А.О. – лаборант-исследователь лаборатории геномной медицины отдела экспериментальной медицины </p><p>г. Кемерово</p></bio><bio xml:lang="en"><p>Poddubnyak A.O., Research Laboratory Assistant, Laboratory of Genomic Medicine, Department of Experimental Medicine </p><p>Kemerovo</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Понасенко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ponasenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Понасенко А.В. – к.м.н., заведующая лабораторией геномной медицины отдела экспериментальной медицины </p><p>г. Кемерово</p></bio><bio xml:lang="en"><p>Ponasenko A.V., PhD (Medicine), Head, Laboratory of Genomic Medicine, Department of Experimental Medicine </p><p>Kemerovo</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute for Complex Issues of Cardiovascular Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>16</day><month>10</month><year>2023</year></pub-date><volume>26</volume><issue>6</issue><fpage>1223</fpage><lpage>1234</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Синицкая А.В., Синицкий М.Ю., Казачек Я.В., Евтушенко А.В., Хуторная М.В., Асанов М.А., Поддубняк А.О., Понасенко А.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Синицкая А.В., Синицкий М.Ю., Казачек Я.В., Евтушенко А.В., Хуторная М.В., Асанов М.А., Поддубняк А.О., Понасенко А.В.</copyright-holder><copyright-holder xml:lang="en">Sinitskaya A.V., Sinitsky M.Y., Kazachek Y.V., Evtushenko A.V., Khutornaya M.V., Asanov M.A., Poddubnyak A.O., Ponasenko A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2869">https://www.mimmun.ru/mimmun/article/view/2869</self-uri><abstract><p>Инфекционный эндокардит характеризуется дисфункцией клапанов сердца и вносит значительный вклад в структуру заболеваемости и смертности среди всех патологий сердечно-сосудистой системы. Иммунный ответ играет важную роль в патофизиологии данного заболевания. Структурные модификации в генах, кодирующих молекулы, вовлеченные в иммунный ответ, а также изменение их экспрессии, могут приводит к изменению функциональной активности и количества синтезируемых белков, что, в свою очередь, оказывает влияние на эффективности иммунного ответа. Целью исследования стала оценка локального профиля цитокинов, экспрессируемых нативными клапанами сердца, полученными от пациентов с инфекционным эндокардитом в процессе кардиохирургического вмешательства. Профиль секретируемых цитокинов изучали в нативных клапанах сердца, полученных от 4 пациентов с инфекционным эндокардитом (экспериментальная группа) и 10 пациентов с ревматической болезнью сердца (контрольная группа) методом дот-блоттинга с использованием наборов Proteome Profiler™ Human Cytokine Array Kit (ARY005B). Результаты дот-блоттинга подтверждали путем оценки уровня экспрессии соответствующих генов с помощью количественной полимеразной цепной реакции после обратной транскрипции с использованием праймеров, синтезированных компанией «Евроген» (Москва, Россия). Белки MIF, PAI-1, ICAM-1 и CXCL12 обнаружены в образцах нативных клапанов как экспериментальной, так и контрольной групп. В результате полуколичественного анализа установлено, что клапаны, пораженные инфекционным эндокардитом, характеризовались четырехкратным повышением секреции PAI-1 и двухкратным снижением секреции молекул ICAM-1 и CXCL12 по сравнению с контрольной группой. MIF экспрессировался на одном и том уже уровне в обеих изученных группах. Белки IL-1ra, IL-6, IL-8, IL-16, CCL4, CCL5 и CXCL1 обнаружены только в клапанах, пораженных инфекционным эндокардитом. Кроме того, показано, что экспериментальная группа характеризовалась повышением экспрессии генов MIF, IL6, IL8; а также снижением уровня мРНК генов PAI1, IL1RA и CXCL1 относительно контроля. Таким образом, нативные клапаны сердца, пораженные инфекционным эндокардитом, характеризуются развитием локального воспаления, вызванного патогенной бактериемией, и активной неоваскуляризацией. </p></abstract><trans-abstract xml:lang="en"><p>Infectious endocarditis is characterized by dysfunction of heart valves and contribute significantly to the cardiovascular morbidity and mortality worldwide, especially in low- and middle-income countries. Immune response is playing the important role in the pathophysiology of this disease. This work was aimed to study the local cytokine profile in native heart valves obtained from the patients with infectious endocarditis. Cytokine profiling were performed in biopsies of native heart valves explanted from 4 patients with infective endocarditis (experimental group) and 10 patients with rheumatic heart disease (comparison group) by dot blotting using the Proteome Profiler™ Human Cytokine Array Kit (ARY005B). The results of dot blotting were validated by the gene expression profiling using quantitative polymerase chain reaction. MIF, PAI-1, ICAM-1 and CXCL12 were found in the native heart valves explanted from both infective endocarditis and rheumatic heart disease patients. Upon a semi-quantitative assessment, the heart valves explanted from the infective endocarditis patients were characterized by 4-fold increased secretion of PAI-1 and twofold decreased secretion of ICAM-1 and CXCL12 compared to the heart valves ffected by rheumatic heart disease. MIF was expressed on similar levels in the both studied groups. IL-1ra, IL-6, IL-8, IL-16, CCL4, CCL5 and CXCL1 were detected only in heart valves affected by infectious endocarditis. At the gene expression level, MIF, IL6, IL8 genes were upregulated and PAI1, IL1RA, CXCL1 genes were downregulated in heart valves explanted from infectious endocarditis patients compared to the subjects affected by rheumatic heart disease. Native heart valves in cases of infectious endocarditis are characterized by nonspecific local inflammatory response associated with pathogenic bacteremia, along with active neovascularization. The data obtained can help to better understand fundamental pathogenetic mechanisms of infectious endocarditis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфекционный эндокардит</kwd><kwd>нативные клапаны сердца</kwd><kwd>патогенная бактериемия</kwd><kwd>воспаление</kwd><kwd>генная экспрессия</kwd><kwd>цитокины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>infectious endocarditis</kwd><kwd>native heart valves</kwd><kwd>pathogenic bacteremia</kwd><kwd>inflammation</kwd><kwd>gene expression</kwd><kwd>proteomic profile</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено при поддержке комплексной программы фундаментальных научных исследований СО РАН в рамках фундаментальной темы НИИ КПССЗ № 0419-2022-0001.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Завырылина И.Н., Барбараш Н.А., Начева Л.В. Паразитарные поражения сердца // Комплексные проблемы сердечно-сосудистых заболеваний, 2012. № 2. С.60-63.</mixed-citation><mixed-citation xml:lang="en">Zavyrylina I.N., Barbarash N.A., Nacheva L.V. The parasitic heart lesions. Kompleksnye problemy serdechno-sosudistykh zabolevaniy = Complex Issues of Cardiovascular Diseases, 2012, no. 2, pp. 60-63. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Синицкий М.Ю., Асанов М.А., Тхоренко Б.А., Одаренко Ю.Н., Понасенко А.В. Микрофлора периферической крови пациентов с инфекционным эндокардитом // Клиническая лабораторная диагностика, 2018. Т. 63, № 10. С. 636-640.</mixed-citation><mixed-citation xml:lang="en">Sinitsky M.Y., Asanov M.A., Tkhorenko B.A., Odarenko Y.N., Ponasenko A.V. Microflora of peripheral blood obtained from patients with infective endocarditis. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics, 2018, Vol. 63, no. 10, pp. 636-640. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Appay V., Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol., 2001, Vol. 22, no. 2, pp. 83-87.</mixed-citation><mixed-citation xml:lang="en">Appay V., Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol., 2001, Vol. 22, no. 2, pp. 83-87.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Araújo I.R., Ferrari T.C., Teixeira-Carvalho A., Campi-Azevedo A.C., Rodrigues L.V., Guimarães Júnior M.H., Barros T.L., Gelape C.L., Sousa G.R., Nunes M.C. Cytokine signature in infective endocarditis. PLoS One, 2015, Vol. 10, no. 7, e0133631. doi: 10.1371/journal.pone.0133631.</mixed-citation><mixed-citation xml:lang="en">Araújo I.R., Ferrari T.C., Teixeira-Carvalho A., Campi-Azevedo A.C., Rodrigues L.V., Guimarães Júnior M.H., Barros T.L., Gelape C.L., Sousa G.R., Nunes M.C. Cytokine signature in infective endocarditis. PLoS One, 2015, Vol. 10, no. 7, e0133631. doi: 10.1371/journal.pone.0133631.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Arend W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev., 2002, Vol. 13, no. 4-5, pp. 323-340.</mixed-citation><mixed-citation xml:lang="en">Arend W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev., 2002, Vol. 13, no. 4-5, pp. 323-340.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Baddour L.M., Wilson W.R., Bayer A.S., Fowler V.G., Tleyjeh I.M., Rybak M.J., Barsic B., Lockhart P.B., Gewitz M.H., Levison M.E., Bolger A.F., Steckelberg J.M., Baltimore R.S., Fink A.M., O’Gara P., Taubert K.A. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the american heart association. Circulation, 2015, Vol. 132, no. 15, pp. 1435-1486.</mixed-citation><mixed-citation xml:lang="en">Baddour L.M., Wilson W.R., Bayer A.S., Fowler V.G., Tleyjeh I.M., Rybak M.J., Barsic B., Lockhart P.B., Gewitz M.H., Levison M.E., Bolger A.F., Steckelberg J.M., Baltimore R.S., Fink A.M., O’Gara P., Taubert K.A. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the american heart association. Circulation, 2015, Vol. 132, no. 15, pp. 1435-1486.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bone R.C. Modulators of coagulation. A critical appraisal of their role in sepsis. Arch. Intern. Med., 1992, Vol. 152, no. 7, pp. 1381-1389.</mixed-citation><mixed-citation xml:lang="en">Bone R.C. Modulators of coagulation. A critical appraisal of their role in sepsis. Arch. Intern. Med., 1992, Vol. 152, no. 7, pp. 1381-1389.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bustamante J., Arévalo A., Tamayo E., Sarria C., Aguilar-Blanco E.M., Heredia M., Almansa R., Rico L., Iglesias V., Bermejo-Martin J.F. Cytokine profiles linked to fatal outcome in infective prosthetic valve endocarditis. APMIS, 2014, Vol. 122, no. 6, pp. 526-529.</mixed-citation><mixed-citation xml:lang="en">Bustamante J., Arévalo A., Tamayo E., Sarria C., Aguilar-Blanco E.M., Heredia M., Almansa R., Rico L., Iglesias V., Bermejo-Martin J.F. Cytokine profiles linked to fatal outcome in infective prosthetic valve endocarditis. APMIS, 2014, Vol. 122, no. 6, pp. 526-529.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE Guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem., 2009, Vol. 55, no. 4, pp. 611-622.</mixed-citation><mixed-citation xml:lang="en">Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE Guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem., 2009, Vol. 55, no. 4, pp. 611-622.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Buyukasýk N.S., Ileri M., Alper A., Senen K., Atak R., Hisar I., Yetkin E., Turhan H., Demirkan D. Increased blood coagulation and platelet activation in patients with infective endocarditis and embolic events. Clin. Cardiol., 2004, Vol. 27, no. 3, pp. 154-158.</mixed-citation><mixed-citation xml:lang="en">Buyukasýk N.S., Ileri M., Alper A., Senen K., Atak R., Hisar I., Yetkin E., Turhan H., Demirkan D. Increased blood coagulation and platelet activation in patients with infective endocarditis and embolic events. Clin. Cardiol., 2004, Vol. 27, no. 3, pp. 154-158.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Clark B.C., Krishnan A., McCarter R., Scheel J., Sable C., Beaton A. Using a low-risk population to estimate the specificity of the World Heart Federation criteria for the diagnosis of rheumatic heart disease. J. Am. Soc. Echocardiogr., 2016, Vol. 29, no. 3, pp. 253-258.</mixed-citation><mixed-citation xml:lang="en">Clark B.C., Krishnan A., McCarter R., Scheel J., Sable C., Beaton A. Using a low-risk population to estimate the specificity of the World Heart Federation criteria for the diagnosis of rheumatic heart disease. J. Am. Soc. Echocardiogr., 2016, Vol. 29, no. 3, pp. 253-258.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Diab M., Tasar R., Sponholz C., Lehmann T., Pletz M.W., Bauer M., Brunkhorst F.M., Doenst T. Changes in inflammatory and vasoactive mediator profiles during valvular surgery with or without infective endocarditis: A case control pilot study. PLoS One, 2020, Vol. 15, no. 2, e0228286. doi: 10.1371/journal.pone.0228286.</mixed-citation><mixed-citation xml:lang="en">Diab M., Tasar R., Sponholz C., Lehmann T., Pletz M.W., Bauer M., Brunkhorst F.M., Doenst T. Changes in inflammatory and vasoactive mediator profiles during valvular surgery with or without infective endocarditis: A case control pilot study. PLoS One, 2020, Vol. 15, no. 2, e0228286. doi: 10.1371/journal.pone.0228286.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gewitz M.H., Baltimore R.S., Tani L.Y., Sable C.A., Shulman S.T., Carapetis J., Remenyi B., Taubert K.A., Bolger A.F., Beerman L., Mayosi B.M., Beaton A., Pandian N.G., Kaplan E.L. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography: a scientific statement from the American Heart Association. Circulation, 2015, Vol. 131, no. 20, pp. 1806-1818.</mixed-citation><mixed-citation xml:lang="en">Gewitz M.H., Baltimore R.S., Tani L.Y., Sable C.A., Shulman S.T., Carapetis J., Remenyi B., Taubert K.A., Bolger A.F., Beerman L., Mayosi B.M., Beaton A., Pandian N.G., Kaplan E.L. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography: a scientific statement from the American Heart Association. Circulation, 2015, Vol. 131, no. 20, pp. 1806-1818.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Golias C., Batistatou A., Bablekos G., Charalabopoulos A., Peschos D., Mitsopoulos P., Charalabopoulos K. Physiology and pathophysiology of selectins, integrins, and IgSF cell adhesion molecules focusing on inflammation. A paradigm model on infectious endocarditis. Cell Commun. Adhes., 2011, Vol. 18, no. 3, pp. 19-32.</mixed-citation><mixed-citation xml:lang="en">Golias C., Batistatou A., Bablekos G., Charalabopoulos A., Peschos D., Mitsopoulos P., Charalabopoulos K. Physiology and pathophysiology of selectins, integrins, and IgSF cell adhesion molecules focusing on inflammation. A paradigm model on infectious endocarditis. Cell Commun. Adhes., 2011, Vol. 18, no. 3, pp. 19-32.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Grammer J.B., Eichinger W.B., Bleiziffer S., Benz M.R., Lange R., Bauernschmitt R. Valvular chondromodulin-1 expression is downregulated in a rabbit model of infective endocarditis. J. Heart Valve Dis., 2007, Vol. 16, no. 6, pp. 623-630.</mixed-citation><mixed-citation xml:lang="en">Grammer J.B., Eichinger W.B., Bleiziffer S., Benz M.R., Lange R., Bauernschmitt R. Valvular chondromodulin-1 expression is downregulated in a rabbit model of infective endocarditis. J. Heart Valve Dis., 2007, Vol. 16, no. 6, pp. 623-630.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Habib G., Lancellotti P., Antunes M.J., Bongiorni M.G., Casalta J.P., Del Zotti F., Dulgheru R., El Khoury G., Erba P.A., Iung B., Miro J.M., Mulder B.J., Plonska-Gosciniak E., Price S., Roos-Hesselink J., Snygg-Martin U., Thuny F., Tornos Mas P., Vilacosta I., Zamorano J.L. ESC Scientific Document Group, 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur. Heart J., 2015, Vol. 36, no. 44, pp. 3075-3128.</mixed-citation><mixed-citation xml:lang="en">Habib G., Lancellotti P., Antunes M.J., Bongiorni M.G., Casalta J.P., Del Zotti F., Dulgheru R., El Khoury G., Erba P.A., Iung B., Miro J.M., Mulder B.J., Plonska-Gosciniak E., Price S., Roos-Hesselink J., Snygg-Martin U., Thuny F., Tornos Mas P., Vilacosta I., Zamorano J.L. ESC Scientific Document Group, 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur. Heart J., 2015, Vol. 36, no. 44, pp. 3075-3128.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Korbecki J., Barczak K., Gutowska I., Chlubek D., Baranowska-Bosiacka I. CXCL1: gene, promoter, regulation of expression, mRNA stability, regulation of activity in the intercellular space. Int. J. Mol. Sci., 2022, Vol. 23, no. 2, 792. doi: 10.3390/ijms23020792.</mixed-citation><mixed-citation xml:lang="en">Korbecki J., Barczak K., Gutowska I., Chlubek D., Baranowska-Bosiacka I. CXCL1: gene, promoter, regulation of expression, mRNA stability, regulation of activity in the intercellular space. Int. J. Mol. Sci., 2022, Vol. 23, no. 2, 792. doi: 10.3390/ijms23020792.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Maghazachi A.A., Al-Aoukaty A., Schall T.J. CC chemokines induce the generation of killer cells from CD56+ cells. Eur. J. Immunol., 1996, Vol. 26, no. 2, pp. 315-319.</mixed-citation><mixed-citation xml:lang="en">Maghazachi A.A., Al-Aoukaty A., Schall T.J. CC chemokines induce the generation of killer cells from CD56+ cells. Eur. J. Immunol., 1996, Vol. 26, no. 2, pp. 315-319.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Malik M., Chen Y.Y., Kienzle M.F., Tomkowicz B.E., Collman R.G., Ptasznik A. Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1 alpha through Lyn kinase. J. Immunol., 2008, Vol. 181, no. 7, pp. 4632-4637.</mixed-citation><mixed-citation xml:lang="en">Malik M., Chen Y.Y., Kienzle M.F., Tomkowicz B.E., Collman R.G., Ptasznik A. Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1 alpha through Lyn kinase. J. Immunol., 2008, Vol. 181, no. 7, pp. 4632-4637.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Marques R.E., Guabiraba R., Russo R.C., Teixeira M.M. Targeting CCL5 in inflammation. Expert Opin. Ther. Targets, 2013, Vol. 17, no. 12, pp. 1439-1460.</mixed-citation><mixed-citation xml:lang="en">Marques R.E., Guabiraba R., Russo R.C., Teixeira M.M. Targeting CCL5 in inflammation. Expert Opin. Ther. Targets, 2013, Vol. 17, no. 12, pp. 1439-1460.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mathy N.L., Scheuer W., Lanzendörfer M., Honold K., Ambrosius D., Norley S., Kurth R. 2000 Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology, 2000, Vol. 100, no. 1, pp. 63-69.</mixed-citation><mixed-citation xml:lang="en">Mathy N.L., Scheuer W., Lanzendörfer M., Honold K., Ambrosius D., Norley S., Kurth R. 2000 Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology, 2000, Vol. 100, no. 1, pp. 63-69.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Maurer M., von Stebut E. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol., 2004, Vol. 36, no. 10, pp. 1882-1886.</mixed-citation><mixed-citation xml:lang="en">Maurer M., von Stebut E. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol., 2004, Vol. 36, no. 10, pp. 1882-1886.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Menten P., Wuyts A., Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev., 2002, Vol. 13, no. 6, pp. 455-481.</mixed-citation><mixed-citation xml:lang="en">Menten P., Wuyts A., Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev., 2002, Vol. 13, no. 6, pp. 455-481.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Perrier S., Darakhshan F., Hajduch E. IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? FEBS Lett., 2006, Vol. 580, no. 27, pp. 6289-6294.</mixed-citation><mixed-citation xml:lang="en">Perrier S., Darakhshan F., Hajduch E. IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? FEBS Lett., 2006, Vol. 580, no. 27, pp. 6289-6294.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Prendergast B.D., Tornos P. Surgery for infective endocarditis: who and when? Circulation, 2010, Vol. 121, no. 9, pp. 1141-1152.</mixed-citation><mixed-citation xml:lang="en">Prendergast B.D., Tornos P. Surgery for infective endocarditis: who and when? Circulation, 2010, Vol. 121, no. 9, pp. 1141-1152.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ris T., Teixeira-Carvalho A., Coelho R.M.P., Brandao-de-Resende C., Gomes M.S., Amaral L.R., Pinto P.H.O.M., Santos L.J.S., Salles J.T., Roos-Hesselink J., Verkaik N., Ferrari T.C.A., Nunes M.C.P. Inflammatory biomarkers in infective endocarditis: machine learning to predict mortality. Clin. Exp. Immunol., 2019, Vol. 196, no. 3, pp. 374-382.</mixed-citation><mixed-citation xml:lang="en">Ris T., Teixeira-Carvalho A., Coelho R.M.P., Brandao-de-Resende C., Gomes M.S., Amaral L.R., Pinto P.H.O.M., Santos L.J.S., Salles J.T., Roos-Hesselink J., Verkaik N., Ferrari T.C.A., Nunes M.C.P. Inflammatory biomarkers in infective endocarditis: machine learning to predict mortality. Clin. Exp. Immunol., 2019, Vol. 196, no. 3, pp. 374-382.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Sillen M., Declerck P.J. Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition. Front. Cardiovasc. Med., 2020, Vol. 7, 622473. doi: 10.3389/fcvm.2020.622473.</mixed-citation><mixed-citation xml:lang="en">Sillen M., Declerck P.J. Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition. Front. Cardiovasc. Med., 2020, Vol. 7, 622473. doi: 10.3389/fcvm.2020.622473.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Souza V.H., Visentainer J.E.L., Zacarias J.M.V., Alencar J.B., Tsuneto P.Y., Silva C.O., Salmeron S., Colli C.M., Sell A.M. Association of IL16 polymorphisms with periodontitis in Brazilians: A case-control study. PLoS One, 2020, Vol. 15, no. 9, e0239101. doi: 10.1371/journal.pone.0239101.</mixed-citation><mixed-citation xml:lang="en">Souza V.H., Visentainer J.E.L., Zacarias J.M.V., Alencar J.B., Tsuneto P.Y., Silva C.O., Salmeron S., Colli C.M., Sell A.M. Association of IL16 polymorphisms with periodontitis in Brazilians: A case-control study. PLoS One, 2020, Vol. 15, no. 9, e0239101. doi: 10.1371/journal.pone.0239101.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Steckelberg J.M., Murphy J.G., Ballard D., Bailey K., Tajik A.J., Taliercio C.P., Giuliani E.R., Wilson W.R. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann. Intern. Med., 1991, vol.114, no. 8, pp. 635-640.</mixed-citation><mixed-citation xml:lang="en">Steckelberg J.M., Murphy J.G., Ballard D., Bailey K., Tajik A.J., Taliercio C.P., Giuliani E.R., Wilson W.R. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann. Intern. Med., 1991, vol.114, no. 8, pp. 635-640.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart A.G., Beart P.M. Inflammation: maladies, models, mechanisms and molecules. Br. J. Pharmacol., 2016, Vol. 173, no. 4, pp. 631-634.</mixed-citation><mixed-citation xml:lang="en">Stewart A.G., Beart P.M. Inflammation: maladies, models, mechanisms and molecules. Br. J. Pharmacol., 2016, Vol. 173, no. 4, pp. 631-634.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">van Tilborg A.A., Sweep F.C., Geurts-Moespot A.J., Wetzels A.M., de Waal R.M., Westphal J.R., Massuger L.F. Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids. Int. J. Oncol., 2014, Vol. 44, no. 4, pp. 1394-1400.</mixed-citation><mixed-citation xml:lang="en">van Tilborg A.A., Sweep F.C., Geurts-Moespot A.J., Wetzels A.M., de Waal R.M., Westphal J.R., Massuger L.F. Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids. Int. J. Oncol., 2014, Vol. 44, no. 4, pp. 1394-1400.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Vandesompele J., De Preter K., Pattyn F., Poppe B., van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 2002, Vol. 3, no. 7, research0034.1. doi: 10.1186/gb-2002-3-7-research0034.</mixed-citation><mixed-citation xml:lang="en">Vandesompele J., De Preter K., Pattyn F., Poppe B., van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 2002, Vol. 3, no. 7, research0034.1. doi: 10.1186/gb-2002-3-7-research0034.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Veltrop M.H., Thompson J., Beekhuizen H. Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells. Infect. Immun., 2011, Vol. 69, no. 5, pp. 2797-2807.</mixed-citation><mixed-citation xml:lang="en">Veltrop M.H., Thompson J., Beekhuizen H. Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells. Infect. Immun., 2011, Vol. 69, no. 5, pp. 2797-2807.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Weinstock M., Grimm I., Dreier J., Knabbe C., Vollmer T. Genetic variants in genes of the inflammatory response in association with infective endocarditis. PLoS One, 2014, Vol. 9, no. 10, e110151. doi: 10.1371/journal.pone.0110151.</mixed-citation><mixed-citation xml:lang="en">Weinstock M., Grimm I., Dreier J., Knabbe C., Vollmer T. Genetic variants in genes of the inflammatory response in association with infective endocarditis. PLoS One, 2014, Vol. 9, no. 10, e110151. doi: 10.1371/journal.pone.0110151.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson C., Purcell C., Seaton A., Oladipo O., Maxwell P.J., O’Sullivan J.M., Wilson R.H., Johnston P.G., Waugh D.J. Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis. J. Pharmacol. Exp. Ther., 2008, Vol. 327, no. 3, pp. 746-759.</mixed-citation><mixed-citation xml:lang="en">Wilson C., Purcell C., Seaton A., Oladipo O., Maxwell P.J., O’Sullivan J.M., Wilson R.H., Johnston P.G., Waugh D.J. Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis. J. Pharmacol. Exp. Ther., 2008, Vol. 327, no. 3, pp. 746-759.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Yamauchi R., Tanaka M., Kume N., Minami M., Kawamoto T., Togi K., Shimaoka T., Takahashi S., Yamaguchi J., Nishina T., Kitaichi M., Komeda M., Manabe T., Yonehara S., Kita T. Upregulation of SR-PSOX/ CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler. Thromb. Vasc. Biol., 2004, Vol. 24, no. 2, pp. 282-287.</mixed-citation><mixed-citation xml:lang="en">Yamauchi R., Tanaka M., Kume N., Minami M., Kawamoto T., Togi K., Shimaoka T., Takahashi S., Yamaguchi J., Nishina T., Kitaichi M., Komeda M., Manabe T., Yonehara S., Kita T. Upregulation of SR-PSOX/ CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler. Thromb. Vasc. Biol., 2004, Vol. 24, no. 2, pp. 282-287.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Yeh C.Y., Shun C.T., Kuo Y.M., Jung C.J., Hsieh S.C., Chiu Y.L., Chen J.W., Hsu R.B., Yang C.J., Chia J.S. Activated human valvular interstitial cells sustain interleukin-17 production to recruit neutrophils in infective endocarditis. Infect. Immun., 2015, Vol. 83, no. 6, pp. 2202-2212.</mixed-citation><mixed-citation xml:lang="en">Yeh C.Y., Shun C.T., Kuo Y.M., Jung C.J., Hsieh S.C., Chiu Y.L., Chen J.W., Hsu R.B., Yang C.J., Chia J.S. Activated human valvular interstitial cells sustain interleukin-17 production to recruit neutrophils in infective endocarditis. Infect. Immun., 2015, Vol. 83, no. 6, pp. 2202-2212.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
